Tacmoy, Angeline .
HRN: 23-54-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2023
CEFTRIAXONE 1G (VIAL)
08/16/2023
08/23/2023
IV
285mg
BID
TC Typhoid Fever, R/O Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes